All In MedTech

FDA Clearance Tracker · K243849

2430TCA with Xmaru W

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Mar 12, 2025 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Mar 12, 2025

Substantially Equivalent

Time to decision

86 days

Received Dec 16, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K243849
Device name
2430TCA with Xmaru W
Applicant location
Hwaseong-Si, KR
Received
Dec 16, 2024
Decided
Mar 12, 2025
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 892.1715

Every decision under product code MUE

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MUE. The earliest in FDA's data is P990066, decided Jan 28, 2000.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Rayence Co., Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.